Differential expression of two isoforms of the neurokinin-1 (substance P) receptor in vivo

1996 ◽  
Vol 719 (1-2) ◽  
pp. 8-13 ◽  
Author(s):  
Patrick W. Mantyh ◽  
Scott D. Rogers ◽  
Joseph R. Ghilardi ◽  
John E. Maggio ◽  
Christopher R. Mantyh ◽  
...  
1998 ◽  
Vol 84 (4) ◽  
pp. 1431-1436 ◽  
Author(s):  
Xiao-Pei Gao

The purpose of this study was to determine whether an aqueous extract of grain sorghum dust increases macromolecular efflux from the nasal mucosa in vivo and, if so, whether this response is mediated, in part, by substance P. Suffusion of grain sorghum dust extract on the in situ nasal mucosa of anesthetized hamsters elicits a significant increase in clearance of fluorescein isothiocyanate-labeled dextran (FITC-dextran; mol mass, 70 kDa; P < 0.05). This response is significantly attenuated by CP-96345 and RP-67580, two selective, but structurally distinct, nonpeptide neurokinin 1 (substance P)-receptor antagonists, but not by CP-96344, the 2 R,3 Renantiomer of CP-96345 ( P < 0.05). CP-96345 has no significant effects on adenosine-induced increase in clearance of FITC-dextran from the in situ nasal mucosa. CP-96345 and RP-67580, but not CP-96344, significantly attenuate substance P-induced increases in clearance of FITC-dextran from the in situ nasal mucosa ( P < 0.05). Collectively, these data suggest that grain sorghum dust elicits neurogenic plasma exudation from the in situ nasal mucosa.


2007 ◽  
Vol 292 (4) ◽  
pp. L915-L923 ◽  
Author(s):  
Jaime Chávez ◽  
Patricia Segura ◽  
Mario H. Vargas ◽  
José Luis Arreola ◽  
Edgar Flores-Soto ◽  
...  

Organophosphates induce bronchoobstruction in guinea pigs, and salbutamol only transiently reverses this effect, suggesting that it triggers additional obstructive mechanisms. To further explore this phenomenon, in vivo (barometric plethysmography) and in vitro (organ baths, including ACh and substance P concentration measurement by HPLC and immunoassay, respectively; intracellular Ca2+ measurement in single myocytes) experiments were performed. In in vivo experiments, parathion caused a progressive bronchoobstruction until a plateau was reached. Administration of salbutamol during this plateau decreased bronchoobstruction up to 22% in the first 5 min, but thereafter airway obstruction rose again as to reach the same intensity as before salbutamol. Aminophylline caused a sustained decrement (71%) of the parathion-induced bronchoobstruction. In in vitro studies, paraoxon produced a sustained contraction of tracheal rings, which was fully blocked by atropine but not by TTX, ω-conotoxin (CTX), or epithelium removal. During the paraoxon-induced contraction, salbutamol caused a temporary relaxation of ∼50%, followed by a partial recontraction. This paradoxical recontraction was avoided by the M2- or neurokinin-1 (NK1)-receptor antagonists (methoctramine or AF-DX 116, and L-732138, respectively), accompanied by a long-lasting relaxation. Forskolin caused full relaxation of the paraoxon response. Substance P and, to a lesser extent, ACh released from tracheal rings during 60-min incubation with paraoxon or physostigmine, respectively, were significantly increased when salbutamol was administered in the second half of this period. In myocytes, paraoxon did not produce any change in the intracellular Ca2+ basal levels. Our results suggested that: 1) organophosphates caused smooth muscle contraction by accumulation of ACh released through a TTX- and CTX-resistant mechanism; 2) during such contraction, salbutamol relaxation is functionally antagonized by the stimulation of M2 receptors; and 3) after this transient salbutamol-induced relaxation, a paradoxical contraction ensues due to the subsequent release of substance P.


1989 ◽  
Vol 86 (13) ◽  
pp. 5193-5197 ◽  
Author(s):  
P. W. Mantyh ◽  
D. J. Johnson ◽  
C. G. Boehmer ◽  
M. D. Catton ◽  
H. V. Vinters ◽  
...  

2017 ◽  
Vol 21 (7) ◽  
pp. 1277-1284 ◽  
Author(s):  
S.C. Warner ◽  
D.A. Walsh ◽  
L.L. Laslett ◽  
R.A. Maciewicz ◽  
A. Soni ◽  
...  

2010 ◽  
Vol 67 (4) ◽  
pp. e25-e26
Author(s):  
Åsa Michelgård Palmquist ◽  
Anna Pissiota ◽  
Örjan Frans ◽  
Fredrik Åhs ◽  
Bengt Långström ◽  
...  

2009 ◽  
Vol 66 (1) ◽  
pp. 94-97 ◽  
Author(s):  
Yota Fujimura ◽  
Fumihiko Yasuno ◽  
Amanda Farris ◽  
Jeih-San Liow ◽  
Marilla Geraci ◽  
...  

2000 ◽  
Vol 279 (3) ◽  
pp. L477-L486 ◽  
Author(s):  
Christopher M. Evans ◽  
Kristen E. Belmonte ◽  
Richard W. Costello ◽  
David B. Jacoby ◽  
Gerald J. Gleich ◽  
...  

Neuronal muscarinic (M2) receptors inhibit release of acetylcholine from the vagus nerves. Hyperreactivity in antigen-challenged guinea pigs is due to blockade of these M2 autoreceptors by eosinophil major basic protein (MBP) increasing the release of acetylcholine. In vivo, substance P-induced hyperactivity is vagally mediated. Because substance P induces eosinophil degranulation, we tested whether substance P-induced hyperreactivity is mediated by release of MBP and neuronal M2 receptor dysfunction. Pathogen-free guinea pigs were anesthetized and ventilated. Thirty minutes after intravenous administration of [Sar9,Met(O2)11]- substance P, guinea pigs were hyperreactive to vagal stimulation and M2 receptors were dysfunctional. The depletion of inflammatory cells with cyclophosphamide or the administration of an MBP antibody or a neurokinin-1 (NK1) receptor antagonist (SR-140333) all prevented substance P-induced M2dysfunction and hyperreactivity. Intravenous heparin acutely reversed M2 receptor dysfunction and hyperreactivity. Thus substance P releases MBP from eosinophils resident in the lungs by stimulating NK1 receptors. Substance P-induced hyperreactivity is mediated by blockade of inhibitory neuronal M2 receptors by MBP, resulting in increased release of acetylcholine.


Sign in / Sign up

Export Citation Format

Share Document